From: Cost utility analysis of the SQ® HDM SLIT-tablet in house dust mite allergic asthma patients in a German setting
Utility at baseline—all patients
Change from baseline
Utility adopted in analysis
Placebo
ACARIZAX
p value
0.736
0.0059
0.0315
0.0318
0.742
0.768